Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thrombocytopenia 2 Solid Tumor 1 Ovarian Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Glioblastoma 1

Interventions

Carboplatin 44 Paclitaxel 43 liposomal doxorubicin 23 Topotecan 19 Gemcitabine 18 pembrolizumab 17 Cyclophosphamide 17 Bevacizumab 16 Cisplatin 12 niraparib 9 olaparib 8 fludarabine 7 Taxes 7 Docetaxel 7 aldesleukin 6 Nivolumab 6 Doxorubicin 6 1-dodecylpyridoxal 6 oregovomab 5 fludarabine phosphate 5 Peripheral Blood Stem Cell Transplantation 5 Filgrastim 5 rucaparib 4 durvalumab 4 avelumab 4 Surgical Procedures, Operative 4 Melphalan 4 Ipilimumab 4 Interleukin-2 4 Etoposide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Ovarian Neoplasms × romiplostim × Clear all

NCT03622931 2021-02-08

TRACEII

Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH

Phase 2 Terminated

Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡